Empowering Industries Nationwide with Cutting-Edge Healthcare Intelligence
Guidepoint Qsight is a leading research enablement platform designed to advance understanding and empower our clients’ decision-making processes. Powered by innovative technology, real-time data, and hard-to-source expertise, we help our clients turn answers into action.
Backed by a network of nearly 1.625 million experts and Guidepoint’s 1,300 employees worldwide, we inform leading organizations’ research by delivering on-demand intelligence and research on request. Focused exclusively on the healthcare space, our dedicated team of experienced clinicians, data scientists, and domain specialists works to reveal usage and purchasing patterns in the industry’s most dynamic markets. Qsight guides clients in extracting critical insights from the data, delivering a comprehensive product-level understanding of the market, and facilitating analysis for absolute clarity.
The Qsight Story
Beginning with Guidepoint’s acquisition of Quanton Data in 2016, Guidepoint Qsight has been a leader in advanced healthcare market intelligence.
Given the influx of alternative data in the marketplace, it’s often challenging to know what data brings value and what data is simply noise. Grounded in a wealth of proprietary data, Guidepoint Qsight’s purpose is to provide an unprecedented window into patient demands, competitive landscapes, and emerging business trends, enabling a harmonized integration of both quantitative and qualitative data into strategic planning.
Managing Director of Guidepoint’s Data Insights Team
Meet Our Team
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
How Data is Transforming the Medical Aesthetics Market in 2025
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
Crush Your Quota with Qsight Prospector: The “One Call Close” Just Got Closer
One of the biggest challenges in the medical aesthetics industry is meeting aggressive sales quotas—a hurdle that can lead to burnout, high turnover, and diminishing motivation. Enter Qsight Prospector: the industry’s first data-powered tool designed to empower sales teams with precision-targeted insights.
Energy-Based Devices vs. Dermal Fillers: The Shifting Landscape in Aesthetic Spending
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
Our Newest Product Unleashed: Qsight Prospector
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.